Morgan Stanley Starts IO Biotech (IOBT) at Overweight
Tweet
Share
E-mailGet Alerts IOBT Hot Sheet
Price: $0.05 --0%
Rating Summary:
1 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
1 Buy, 3 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison initiates coverage on IO Biotech (NASDAQ: IOBT) with a Overweight rating and a price target of $21.00.
For an analyst ratings summary and ratings history on IO Biotech click here. For more ratings news on IO Biotech click here.
Shares of IO Biotech closed at $8.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Citi Resumes Universal Music Group NV (UMG:NA) (UMGNF) at Buy
- Citi Starts Federal Signal (FSS) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
